DR. JONATHAN D GLASS, M.D.
Neurology at Clifton Rd, Atlanta, GA
License number
Georgia 42254
Category
Neurology
Type
Neurology
Address
Address
1365 Clifton Rd NE, Atlanta, GA 30322
Phone
(404) 778-3444
Personal information
See more information about JONATHAN D GLASS at radaris.comName
Address
Phone
3710 Sandy Cir, Macon, GA 31216
40 Maddox Dr NE, Atlanta, GA 30309
3390 River Heights Xing SE, Marietta, GA 30067
2783 Field Creek Ct NE, Marietta, GA 30062
3196 Mount Zion Rd, Stockbridge, GA 30281
Professional information
Jonathan Glass
Location:
Greater Atlanta Area
Industry:
Computer & Network Security
Skills:
Information Security, Linux, Team Leadership, Public Speaking, Network Security, Security, Computer Security, Disaster Recovery, Firewalls, TCP/IP
Certifications:
ITIL Foundation Certificate in IT Service Management, PEOPLECERT / ITIL
Dr. Jonathan D Glass, Atlanta GA - MD (Doctor of Medicine)
Specialties:
Clinical Neurophysiology, Neuropathology
Address:
Emory Clinic Neurology
1365 Clifton Rd NE, Atlanta 30322
(404) 778-3444 (Phone)
1365 Clifton Rd NE, Atlanta 30322
(404) 778-3444 (Phone)
Certifications:
Clinical Neurophysiology, 1996, Neurology, 1990, Neuropathology, 1997
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Emory Clinic Neurology
1365 Clifton Rd NE, Atlanta 30322
Emory University Hospital
1364 Clifton Rd North #East, Atlanta 30322
1365 Clifton Rd NE, Atlanta 30322
Emory University Hospital
1364 Clifton Rd North #East, Atlanta 30322
Education:
Medical School
University Of Vermont College Of Medicine
Graduated: 1985
University MD
Graduated: 1986
Johns Hopkins University
Graduated: 1989
Graduated: 1991
University Of Vermont College Of Medicine
Graduated: 1985
University MD
Graduated: 1986
Johns Hopkins University
Graduated: 1989
Graduated: 1991
Jonathan D Glass, Atlanta GA
Specialties:
Neurologist
Address:
1365 Clifton Rd Ne, Atlanta, GA 30322
Education:
University of Vermont, College of Medicine - Doctor of Medicine
Johns Hopkins Hospital - Fellowship - Neurological Pathology and Neurology
Johns Hopkins Hospital - Residency - Neurology
Johns Hopkins Hospital - Fellowship - Neurological Pathology and Neurology
Johns Hopkins Hospital - Residency - Neurology
Board certifications:
American Board of Pathology Sub-certificate in Neuropathology (Pathology), American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology)
Jonathan David Glass, Atlanta GA
Specialties:
Neurology, Clinical Neurophysiology, Neuropathology
Work:
The Emory Clinic 'B'
1365 Clifton Rd Ne, Atlanta, GA 30322 The Emory Clin
The Emory Clinic 'B', Atlanta, GA 30322
1365 Clifton Rd Ne, Atlanta, GA 30322 The Emory Clin
The Emory Clinic 'B', Atlanta, GA 30322
Education:
University of Vermont (1985)
Aza-Peptide Epoxides
US Patent:
8013014, Sep 6, 2011
Filed:
Jan 24, 2006
Appl. No.:
11/338147
Inventors:
James C. Powers - Atlanta GA, US
Jonathan D. Glass - Atlanta GA, US
Jonathan D. Glass - Atlanta GA, US
Assignee:
Georgia Tech Research Corporation - Atlanta GA
International Classification:
A61K 31/335
US Classification:
514475
Abstract:
Methods for treatment and/or prevention of nerve degeneration in mammals using aza-peptide epoxide caspase inhibitors are provided. Aspects of the present disclosure include aza-peptide epoxide compositions to treat or prevent diseases, for example stroke, Alzheimer's disease, Parkinson's disease, multiple sclerosis, neuropathies, Huntington's disease, dentatorubropallidoluysian atrophy, spinocerebellar atrophies, spinal bulbar muscular atrophy, diabetes, amyotrophic lateral sclerosis and other motor neuron diseases. The disclosed methods can be used in combination with calpain inhibitors to treat disease or pathological conditions related to the activity of caspases and calpain associated with a specific disease or condition. Such treatable conditions include stroke, Alzheimer's disease, Parkinson's disease, multiple sclerosis, neuropathies, Huntington's disease, dentatorubropallidoluysian atrophy, spinocerebellar atrophies, spinal bulbar muscular atrophy, nerve degeneration associated with diabetes, amyotrophic lateral sclerosis and other motor neuron diseases, nerve degeneration secondary to primary demyelinating disorders, among others.
Heterocyclic Peptide Ketoamides
US Patent:
8518885, Aug 27, 2013
Filed:
Jul 16, 2008
Appl. No.:
12/866541
Inventors:
James C. Powers - Atlanta GA, US
Jonathan D. Glass - Atlanta GA, US
Asli Ovat - Smyrna GA, US
Zhaozhao Li - Alpharetta GA, US
Jonathan D. Glass - Atlanta GA, US
Asli Ovat - Smyrna GA, US
Zhaozhao Li - Alpharetta GA, US
Assignee:
Georgia Tech Research Corporation - Atlanta GA
Emory University - Atlanta GA
Emory University - Atlanta GA
International Classification:
A61K 38/05, C07K 5/06
US Classification:
514 177, 514 178, 514 179, 514 182, 514 202, 514 2191, 544265, 544277, 544316, 544317, 544329, 544335, 564153
Abstract:
A novel class of peptide α-ketoamides useful for selectively inhibiting calpains, selectively inhibiting cysteine proteases, and generally inhibiting all cysteine proteases, having the formula M-AA-AA-CO—NH—(CH)—R. Processes for the synthesis of peptidyl α-ketoamide derivatives. Compositions and methods for inhibiting cysteine proteases, inhibiting calpains, and treating disease caused by cysteine proteases and calpains are provided.
Introduction Of The Wld Gene For Prevention Of Axonal Degeneration In Neurological Diseases
US Patent:
2004012, Jul 1, 2004
Filed:
Jan 15, 2004
Appl. No.:
10/433035
Inventors:
Jonathan Glass - Atlanta GA, US
Mark Rich - Decatur GA, US
Mark Rich - Decatur GA, US
International Classification:
A61K048/00
US Classification:
514/044000
Abstract:
Polypeptides that can protect axons from axon degeneration and methods of use of the polypeptides are presented. Polynucleotides that can protect axons from axon degeneration and methods of use of the polynucleotides are presented. In addition, polynucleotides that encode the polypeptides referred to above are presented. Further, pharmaceutical compositions to treat conditions are presented.
Ketoamide Inhibitors In Chronic Nerve Disease
US Patent:
2004012, Jul 1, 2004
Filed:
Sep 25, 2003
Appl. No.:
10/671360
Inventors:
James Powers - Atlanta GA, US
Jonathan Glass - Atlanta GA, US
Jonathan Glass - Atlanta GA, US
International Classification:
A61K038/04
US Classification:
514/019000
Abstract:
Compositions and methods for treating neural pathologies are provided. In particular, compositions and methods for treating neural pathologies including axonal degeneration are provided. The compositions include peptide -ketomides optionally in combination with a second therapeutic agent. Another aspect of the invention provides compositions and methods for treating hyperproliferative disorders. Exemplary compositions for treating hyperproliferative disorders include an anti-proliferative agent such as paclitaxel, in combination with a calpain inhibitor such as AK295.